Friday, Apr 26, 2024 | Last Update : 03:58 PM IST

Cheap COVID-19 vaccine

AstraZeneca offices and the corporate logo in Cambridge, England. AstraZeneca says late-stage trials of its COVID-19 vaccine were "highly effective'' in preventing disease. A vaccine developed by AstraZeneca and the University of Oxford prevented 70% of people from developing the coronavirus in late-stage trials, the team reported Monday Nov. 23, 2020.(AP)

No severe safety event on Covid vaccine: AstraZeneca

There were 23,000 participants being assessed, who among them would be following two regimes of half dose and full dose

24 Nov 2020 2:05 AM


1 of 1
ADVERTISEMENT

MOST POPULAR

1

Clean chit for Aryan Khan in cruise drugs case

2

'Chak de phatte India', says Harnaaz Sandhu after becoming Miss Universe 2021

3

Mutation linked to remdesivir resistance found in Covid patient

4

Climate finance isn’t charity, says Union minister Bhupender Yadav at COP26 summit

5

Indian origin astronaut-led NASA's SpaceX Crew-3 team headed to ISS

more
ADVERTISEMENT

Columns

Sunil Gatade

Sunil Gatade

Sunil Gatade | Is the absence of a ‘big idea’ hurting the BJP?

Analysis reveals Prime Minister Modi's diminishing impact as opposition highlights governance failures and divisive tactics.

Dilip Cherian

Dilip Cherian

Dilip Cherian | Wheels of discord: IPS officer in Haryana has an odd complaint

Senior IPS Officer Y. Puran Kumar Raises Eyebrows with Complaint of Car Discrimination Amid Lok Sabha Elections

Sanjeev Ahluwalia

Sanjeev Ahluwalia

Sanjeev Ahluwalia | The choice in Elections 2024: A grand spectacle or a wake?

Modi's "Guarantee 2024" vs Congress' "Nyay Patra" - A Clash of Narratives

Aakar Patel

Aakar Patel

Aakar Patel | If India becomes a Hindu Rashtra, will there be any difference at all?

Exploring the historical context and implications of the term "Hindu Rashtra" in light of constitutional and legal frameworks.

more

Copyright © 2016 - 2024 The Asian Age. Designed, Developed & Maintained By Daksham